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544a Tuesday, February 28, 2012largest (and smallest) APD-values were selected to create a maximum (and min-
imum) APD-map. This illustrated the variability-range per slice which, as an ex-
ample for APD80 at 2Hz, was 196.37ms56.59ms (maximum; mean5SD),
187.00ms56.57ms (minimum), and 191.69ms55.44ms (average). Interestingly,
even though the spread of activation differed significantly for the different stimu-
lus sites, resulting APD-maps were comparable for all pacing rates in homoge-
neous slices (i.e. in the absence of pronounced source-sink mismatches).
Thus, APD heterogeneity in cardiac tissue slices shows a reproducible intrinsic
pattern that prevails regardless of acute changes in stimulation site and frequency.
Claycomb. J Biol Chem. 1976/251:P6082-P6089.
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The lack of a reliable and standardized in vitro cardiac myocyte cell culture
model hampers the development of new cardiac drugs and leads to costly
late stage failures of potential drug candidates.
Pluripotent stem cell-derived cardiomyocytes have the capacity to bridge this
gap. The standarized production process, the availability of large frozen stocks,
and the long-term stability in culture make them an attractive in vitro model.
Now cardiomyocytes originated from various species and different kinds of
stem cells are available. These cells are only as good as the predictivity, as mea-
sured against human clinical data, of the assays that have been developed for
them. Genetically selected mouse embryonic stem cell-derived cardiomyocytes
were successfully used in a variety of electrophysiological assay systems in-
cluding high throughput FLIPR fluo-4 and membrane potential assays (up to
1536 well format) as well as rubidium flux assays. The cells were also used
in high content assay systems like automated voltage and current clamp and mi-
croelectrode array recordings and long-term recording in impedance-based as-
say systems. Each technique has their advantages and particular application.
We can show high predictivity in their application in the assessment of drug
efficacy and safety for many cardiac targets.
Furthermore, we have established and validated a cardiac cytotoxicity assay
based on pluripotent stem cell-derived cardiomyocytes to predict drug-
induced cardiac-specific cytotoxicity of different compound classes including
anthracyclines as well as tyrosine kinase inhibitors.
Taken together, these assays can be implemented early in the drug optimization
and development process and will reduce costly in vivo studies and will help to
prevent late stage drug candidate failures.
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There is increasing interest for cardiomyocytes as models for studying cardiac
cellular physiology and preclinical drug safety testing. Stem cell-derived cardi-
omyocytes have the potential for such a model and have the possibility for mod-
eling human diseases. The present investigation is the first to describe current
properties from stem cell-derived cardiomyocytes using multi-hole recordings
with planar automated patch clamp technology.
In our study pluripotent stem cell-derived cardiomyocytes were biophysically
and pharmacologically characterized. The cells are differentiated in large num-
bers and cryo-preserved, which make them suitable for automated patch clamp-
ing and facilitate their use in drug screening. We tested the cells in two different
recording modes; single-hole and multi-hole, respectively. For multi-hole re-
cordings up to ten cells are patched at the same time and the total current is mea-
sured per site. This recording mode can be useful for small currents (e.g.
endogenous) and typically increases the success rate for useful data. For all ex-
periments the whole-cell configuration was used and three different types of cur-
rents were studied; Naþ, Ca2þ and Kþ. Using specific voltage protocols
biophysical characteristics of each current was described and compared from
single-hole and multi-hole experiments. We showed that currents recorded
from these pluripotent stem cell-derived cardiomyocytes are similar to human
cardiomyocytes and the response to known pharmacology is as expected. The
V0.5 values, I-V relationships, current kinetics and IC50 values determined for
known blockers (TTX, nifedipine and cisapride) were comparable for the tworecording modes. Clearly the success rate for usable data per measurement plate
was significantly increased with the multi-hole technology. This is the first time
current properties of stem cell-derived cardiomyocytes have been described
from multi-hole recordings with planar automated patch clamp. Our study has
shown that automated patch clamp is ready for stem cell-derived exploration.
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The action potential (AP) of a cardiac cell is a finely choreographed dance in-
volving many ion channels and transporters interacting with one another via
membrane potential and intracellular Ca2þ. The ionic mechanisms that cause
arrhythmogenic APs (early or delayed afterdepolarizations, short or long AP
duration) are still incompletely understood. Traditional voltage-clamp experi-
ments measured one current from one cell and in most cases without Ca2þ tran-
sients. Data averaged from many cells were then used to build a canonical AP
model. However, the canonical AP may be very different from the AP of any
particular cell due to cell-to-cell variations. Recently, we developed an innova-
tive ‘Onion-Peeling’ (O-P) technique to achieve (a) a direct recording of ionic
current under in situ condition (during AP, with Ca2þ cycling, in a physiological
milieu, undergoing contraction) and (b) recording of multiple currents from
a single cell to study how different currents interact and integrate to shape
AP. Here we report the results of using O-P to investigate: (1) recording of
key ionic currents (IKs, IKr, IK1, ICa,L, INCX , INa-Late) during AP in the guinea
pig ventricular myocyte; (2) effects of the Ca2þ transient on modulating these
currents during AP; (3) changes of multiple currents under beta-adrenergic
stimulation and how concerted changes in currents integrate to reshape AP.
The ability to measure many currents in a single cell has also revealed two hith-
erto unknown characteristics of the currents in cardiac cells: coordination of
currents within a cell and large variations of currents between cells. Hence,
our O-P technique presents a significant step beyond the traditional way of
measuring only one current in any one cell, and provides a powerful new
tool for studying the individual cell electrophysiology.
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The electrophysiological properties of cardiomyocytes are fascinating yet com-
plex. A finely tuned composition of different ion channel classes is necessary
for the precise execution of an action potential. Modification of channel subsets
by pharmacological substances or by genetic mutations can disturb the timing of
electrical excitation cumulating in life threatening arrhythmias of the entire heart.
Heart pathologies can be studied in different sets from cellular to organ level.
Here we are going to discuss the advantages and limitations of different prep-
arations and techniques applied in our lab, including 1) patch clamp analysis of
adult cardiomyocytes cultivated for up to 7 days without showing major ion
channel dedifferentiation, 2) microelectrode array (MEA) recordings of electri-
cally coupled embryonic cardiomyocytes to study cardiac excitation, signal
propagation and antiarrhythmic drug effects on a multicellular level, 3) Human
stem cell derived cardiomyocyte technology and their potential for safety phar-
macology screening, 4) acute and cultivated ventricular heart slices from differ-
ent species including humans as test platform for drug screening in intact tissue
and 5) Flex-MEA technology to perform extracellular recordings in intact beat-
ing hearts in a Langendorff preparation.
Parts of the work has been funded by the Bundesministerium fu¨r Bildung und
Forschung (BMBF) /01GG0710
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Understanding the importance of spatial and temporal regulation of cellular com-
munity size and shape are keys to resolve mechanisms in highly complex heart
system by new quasi-in vivo assay, which can predict the phenomenon in vivo us-
ing in vitro assay. For that, an on-chip cell network cultivation system has been
